Risk Of Developing Liver Cancer After HCV Treatment

Monday, August 8, 2016

Why are hepatitis C patients treated differently by NHS England?

Why are hepatitis C patients treated differently by NHS England?
8 AUG 2016 10:01 By Charles Gore

NHS England’s decision to cap access to National Institute for Health and Care Excellence (NICE) approved hepatitis C treatments has been attributed to their cost. These antiviral medicines have led to vast costs for national healthcare systems and huge profits for the pharmaceutical industry. So it is understandable that the mainstream media and general public assume that the cost to the NHS (either per patient or in absolute terms) is prohibitive.

Continue reading....


No comments:

Post a Comment